Mixed fortunes for major CROs in Q1
May 7, 2010Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
Encouraging data for ThromboGenics and BioInvent product
May 7, 2010BioInvent, Lovenox, ThromboGenics, VTE
An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …
Congress to probe McNeil’s GMP violations
May 7, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …
EMA appoints Alexis Nolte head of quality
May 7, 2010Manufacturing and Production EMA, appointment, manufacturing and production
The European Medicines Agency has appointed Alexis Nolte to head up its Quality of Medicines Sector. He was previously principal …
New audiences, new marketing tools
May 6, 2010Sales and Marketing brand, branding, marketing, marketing ideas
Pharmaceutical industry marketers have for many years focused on turning good products into great brands, developing strong core propositions which …
Congress criticises FDA over contaminated heparin case
May 6, 2010Manufacturing and Production heparin, manufacturing compliance
The US Food and Drug Administration’s follow-up of the contaminated heparin scandal which surfaced in 2008 has been inadequate, according …
AZ signs tuberculosis drug discovery deal
May 6, 2010Research and Development AstraZeneca, India, TB, tuberculosis
AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …
Abbott’s Mark Kontny joins Patheon
May 6, 2010Manufacturing and Production Patheon, appointment, manufacturing and production
Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer. He joins the contract …
Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Greece’s crisis could hit European prices
May 6, 2010Sales and Marketing Greece, industry, parallel trade, prices
GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …
Sanofi signs Indian pain drug development deal
May 5, 2010Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics
Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …
Collaborative cancer drug project targets research efficiency
May 5, 2010Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development
A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …
Digital Pharma: Online medical information influences treatment
May 5, 2010Medical Communications, Sales and Marketing Datapharm, digital patients, patient information
More than half of health searches in the UK result in treatment or management changes, according to new research by …
Virgo expands med ed team
May 5, 2010Medical Communications Virgo, appointment, medical communications
Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard. Katherine joins the agency as editorial …
More quality issues dog J&J
May 5, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …
Oxford BioMedica hopes vaccine first will raise interest
May 5, 2010Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax
Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …
BMS on tenterhooks over belatacept future
May 4, 2010Research and Development BMS, belatacept
Bristol-Myers Squibb has been kept on tenterhooks by US regulator the FDA over the future of its investigational kidney transplant …
Pfizer still at number 1, but Lipitor to slip
May 4, 2010Sales and Marketing Humira, Lipitor, Pfizer, sales
New research suggests that the pharma world is going to be shaken up over the next few years – although …
Sanofi’s chief strategic officer to step down
May 4, 2010Sales and Marketing Sanofi-Aventis, appointment, sales and marketing
Laurence Debroux, chief strategic officer at Sanofi-Aventis, is to leave the company at the end of June. The company said …
Chiltern Wins Award at the Inaugural US Pharma Awards Ceremony
May 4, 2010Research and Development
Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern’s Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
